Developing and validation of the Sexual Fear Scale in Chinese patients with coronary heart disease.

IF 2 3区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

BMC Cardiovascular Disorders Pub Date : 2025-05-21 DOI:10.1186/s12872-025-04827-0

Fengpei Zhang, Weihong Yang, Yachai Li, Yingying Fan, Xiaoyun Xiong

{"title":"Developing and validation of the Sexual Fear Scale in Chinese patients with coronary heart disease.","authors":"Fengpei Zhang, Weihong Yang, Yachai Li, Yingying Fan, Xiaoyun Xiong","doi":"10.1186/s12872-025-04827-0","DOIUrl":null,"url":null,"abstract":"Background: Sexual fear in patients with coronary heart disease (CHD) can negatively affect their sexual life and overall well-being. However, validated tools for assessing this fear are lacking. This study aimed to develop a sexual fear scale for patients with CHD and evaluate its psychometric properties.Methods: A multi-stage cross-sectional study was conducted with 409 patients. The process included item generation (literature review, expert consultation, and patient interviews), item selection (critical ratio, correlation analysis, and internal consistency), and psychometric evaluation (content validity, reliability, criterion validity, and construct validity via exploratory and confirmatory factor analysis).Results: Finally, a 19-item scale including 2 dimensions of perceived risk and fear psychology was formed. After reliability and validity test, the content validity index of the scale is 0.942, Cronbach's α coefficient is 0.944, test-retest reliability is 0.886, and split-half reliability is 0.841. Two factors extracted from exploratory factor analysis explained 58.655% of the total variation, and confirmatory factor analysis showed that the model fit well.Conclusions: The developed scale demonstrates sound reliability and validity and provides a practical tool for assessing sexual fear in CHD patients, supporting early identification and personalized intervention.Clinical trial number: Not applicable.","PeriodicalId":9195,"journal":{"name":"BMC Cardiovascular Disorders","volume":"25 1","pages":"387"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093691/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cardiovascular Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12872-025-04827-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Sexual fear in patients with coronary heart disease (CHD) can negatively affect their sexual life and overall well-being. However, validated tools for assessing this fear are lacking. This study aimed to develop a sexual fear scale for patients with CHD and evaluate its psychometric properties.

Methods: A multi-stage cross-sectional study was conducted with 409 patients. The process included item generation (literature review, expert consultation, and patient interviews), item selection (critical ratio, correlation analysis, and internal consistency), and psychometric evaluation (content validity, reliability, criterion validity, and construct validity via exploratory and confirmatory factor analysis).

Results: Finally, a 19-item scale including 2 dimensions of perceived risk and fear psychology was formed. After reliability and validity test, the content validity index of the scale is 0.942, Cronbach's α coefficient is 0.944, test-retest reliability is 0.886, and split-half reliability is 0.841. Two factors extracted from exploratory factor analysis explained 58.655% of the total variation, and confirmatory factor analysis showed that the model fit well.

Conclusions: The developed scale demonstrates sound reliability and validity and provides a practical tool for assessing sexual fear in CHD patients, supporting early identification and personalized intervention.

Clinical trial number: Not applicable.

查看原文本刊更多论文

中国冠心病患者性恐惧量表的编制与验证。

背景：冠心病（CHD）患者的性恐惧会对他们的性生活和整体健康产生负面影响。然而，评估这种恐惧的有效工具是缺乏的。本研究旨在编制一套适用于冠心病患者的性恐惧量表，并评估其心理测量学特征。方法：对409例患者进行多阶段横断面研究。该过程包括项目生成（文献回顾、专家咨询和患者访谈）、项目选择（关键比率、相关分析和内部一致性）和心理测量评估（通过探索性和验证性因子分析的内容效度、信度、标准效度和结构效度）。结果：最终形成了包含感知风险和恐惧心理两个维度的19项量表。经信效度检验，量表的内容效度指数为0.942,Cronbach’s α系数为0.944，重测信度为0.886，分半信度为0.841。探索性因子分析提取的两个因子解释了58.655%的总变异，验证性因子分析表明模型拟合良好。结论：所编制的量表具有良好的信度和效度，可作为评估冠心病患者性恐惧的实用工具，支持早期识别和个性化干预。临床试验号：不适用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Cardiovascular Disorders CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

3.50

自引率

0.00%

发文量

480

审稿时长

1 months

期刊介绍： BMC Cardiovascular Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of disorders of the heart and circulatory system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and controlled trials.